Clinical Trial Update: A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating Recaticimab and Adebrelimab in combination with chemotherapy for unresectable biliary tract canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Recaticimab (recaticimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Biliary Tract Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING